Global Pharmaceuticals & Biotech Most Popular Stocks

Daan Gene

Market Cap: CN¥8.8b

Researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China.

Sanofi India

Market Cap: ₹109.4b

Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Dezhan Healthcare

Market Cap: CN¥8.8b

Engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China.

Tourmaline Bio

Market Cap: US$1.2b

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Kissei Pharmaceutical

Market Cap: JP¥184.2b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Amoy Diagnostics

Market Cap: CN¥8.7b

Engages in the development and commercialization of diagnostics product for oncology in China and internationally.

Zymeworks

Market Cap: US$1.2b

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

Sionna Therapeutics

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

Shanghai Medicilon

Market Cap: CN¥8.6b

A contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.

Oscotec

Market Cap: ₩1.7t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

CureVac

Market Cap: US$1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Guilin Sanjin Pharmaceutical

Market Cap: CN¥8.5b

Engages in the research, production, and sale of traditional Chinese and natural medicines in China.

SanBio

Market Cap: JP¥179.0b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

Jiangsu Kanion PharmaceuticalLtd

Market Cap: CN¥8.5b

Researches and develops, produces, and sells Chinese medicines.

Jiuzhitang

Market Cap: CN¥8.5b

Provides traditional Chinese, chemical, biological, and health medicine products in China.

Guangxi Wuzhou Zhongheng Group

Market Cap: CN¥8.5b

Researches, develops, manufactures, and sells pharmaceuticals in China.

Renhe PharmacyLtd

Market Cap: CN¥8.4b

Produces and sells pharmaceutical products.

Procter & Gamble Health

Market Cap: ₹104.2b

Manufactures and markets pharmaceuticals and chemical products in India and internationally.

Beijing Konruns PharmaceuticalLtd

Market Cap: CN¥8.4b

Engages in the research and development, production, and sale of pharmaceuticals in China and internationally.

Innoviva

Market Cap: US$1.2b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

Zhejiang Ausun Pharmaceutical

Market Cap: CN¥8.3b

Engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates.

BioGaia

Market Cap: SEK 10.9b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BioLife Solutions

Market Cap: US$1.2b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Maze Therapeutics

Market Cap: US$1.2b

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Hunan Jiudian Pharmaceutical

Market Cap: CN¥8.2b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Rapport Therapeutics

Market Cap: US$1.2b

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

CK Life Sciences Int'l. (Holdings)

Market Cap: HK$8.9b

An investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America.

LENZ Therapeutics

Market Cap: US$1.1b

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Dynavax Technologies

Market Cap: US$1.1b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Wuhan Keqian BiologyLtd

Market Cap: CN¥8.1b

Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.

Hamlet BioPharma

Market Cap: €965.8m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Philogen

Market Cap: €951.8m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.

Atai Life Sciences

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.